Edwards Reports Strong LifeStent Leg Artery Data, But PMA Will Wait Till ’08
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences reported positive clinical results for its LifeStent femoral/popliteal stent, but FDA is asking for more bench test data for the product's PMA for the femoral indication